M. Eibl
University of Graz
8 Papers
58 Citations
M. Eibl is an academic researcher from University of Graz. The author has contributed to research in topics: Transplantation & Internal medicine. The author has an hindex of 7, co-authored 8 publications.
Chat about Author
Papers
Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate.
TL;DR: It is recommended that antibody therapy with anti-CD33 immunoconjugate should be applied with caution in patients presenting with risk factors for the development of hepatic veno-occlusive disease.
52
Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
Gabriele Halwachs-Baumann,Martie Wilders-Truschnig,Günter Enzinger,M. Eibl,Werner Linkesch,Hans Jürgen Dornbusch,Brigitte I. Santner,Egon Marth,Harald H. Kessler +8 more
TL;DR: Antigenemia was found to be a good screening test for CMV infection in RTX recipients and in BMT recipients, tests based on molecular techniques appeared to be superior compared to antigenemia.
31
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma.
Mikosch P,H.-J. Gallowitsch,W. Zinke-Cerwenka,M. Heinisch,W. Pipam,M. Eibl,E. Kresnik,O. Unterweger,Werner Linkesch,P. Lind +9 more
TL;DR: To achieve a high accuracy in 18F-FDG-PET, the nuclear medicine specialist needs imaging and clinical data as background information, which can only be acquired through close co-operation with the referring clinicians.
26
Amifostine in Combination with Erythropoietin and G-CSF Promotes Multilineage Hematopoiesis in Patients with Myelodysplastic Syndrome
TL;DR: Responsibility was durable only in a minority of patients and thus additional studies are warranted to further define the potential interaction of amifostine and growth factors.
13
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
M. Eibl,Holger W. Auner,Wilma Zinke-Cerwenka,Heinz Sill,Hans Jürgen Dornbusch,Werner Linkesch +5 more
TL;DR: It is demonstrated that high-risk AML with concomitant invasive fungal infection may be safely and effectively treated by nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
12